Location History:
- Cary, NC (US) (1999 - 2012)
- Dallas, TX (US) (2006 - 2022)
Company Filing History:
3 out of 2,198 
2 out of 281 
2 out of 5,506 
Years Active: 1999-2024
Title: Innovations by Steven Anthony Kliewer
Introduction
Steven Anthony Kliewer is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of medical treatments, particularly in addressing secretory disorders. With a total of 8 patents to his name, Kliewer's work has the potential to impact many lives.
Latest Patents
Among his latest patents are methods and compositions for the treatment of exocrine pancreatic insufficiency. This invention relates to the treatment of secretory disorders and provides novel methods of treatment comprising the administration of fibroblast growth factor 21 (FGF21) or derivatives thereof. The methods are useful in conditions including exocrine pancreatic insufficiency (EPI), which can result from various causes such as cystic fibrosis, alcoholism, pancreatitis, pancreatic cancer, gallstones, celiac disease, high triglycerides, or lupus. Additionally, these methods find utility in treating salivary flow disorders, such as Sjögren's syndrome, and in managing EPI or pancreatitis resulting from surgical procedures. Another patent focuses on the use of FGF21 in methods of increasing exocrine pancreatic secretion, further emphasizing Kliewer's commitment to advancing medical treatments.
Career Highlights
Kliewer has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Glaxo Wellcome Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments.
Collaborations
Some of his notable coworkers include Timothy Mark Willson and Jurgen M. Lehmann. Their collaboration has likely fostered an environment of innovation and shared knowledge in their respective fields.
Conclusion
Steven Anthony Kliewer is a distinguished inventor whose work in medical treatments has the potential to improve the quality of life for many individuals suffering from secretory disorders. His contributions to the field are commendable and reflect a dedication to innovation in healthcare.